You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.


( Pom-a-LID-oh-mide )
Exceptional Access Program
  • pomalidomide - For patients with relapsed and/or refractory multiple myeloma, according to specific criteria.
Other Name(s): Pomalyst®
Appearance: capsule in various strengths and colours

You might also be interested in